Status:
COMPLETED
Directly Observed Antiretroviral Therapy Among Active Drug Users
Lead Sponsor:
Yale University
Conditions:
HIV/AIDS
Substance Abuse
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The goal of this randomized, controlled trial is to compare the effectiveness of a community-based program of providing supervised antiretroviral therapy to HIV-positive drug users, compared to having...
Detailed Description
Highly active antiretroviral therapy (HAART) has dramatically reduced morbidity and mortality from HIV disease, but these benefits have not been conferred equally among all patient populations. Inject...
Eligibility Criteria
Inclusion
- being HIV seropositive;
- being eligible for and/or being prescribed HAART
- living within the city of New Haven
- actively using heroin and/or cocaine in the previous six months
- receiving no more than a twice-daily regimen
Exclusion
- Not meeting inclusion criteria
Key Trial Info
Start Date :
June 1 2001
Trial Type :
INTERVENTIONAL
End Date :
December 1 2006
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT00367172
Start Date
June 1 2001
End Date
December 1 2006
Last Update
March 31 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale University School of Medicine
New Haven, Connecticut, United States, 06510